RxDoctor Payments Data

Julie Mallory

Family · Modesto, CANPI 1740506575

Payments from drug & device makers

$3,776in general payments, 2019–2025

Across 120 payments — averaging $31.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$2K
  • AbbVie$619
  • Collegium Pharmaceutical, Inc.$447
  • Biohaven Pharmaceutical Holding Company Ltd.$145
  • Impel Pharmaceuticals Inc.$117
  • Biohaven Pharmaceuticals, Inc.$79
  • plus $541 from 19 others

What the payments were for

  • Travel & lodging$1,29234%
  • Food & beverage$2,46065%
  • Education$241%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,776 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.

See all family providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl98$61,047
Xtampza ErOxycodone Myristate88$40,160
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,326$37,548
Morphine Sulfate ErMorphine Sulfate686$23,574
MovantikNaloxegol Oxalate40$19,662
Fentanyl146$16,885
Hysingla ErHydrocodone Bitartrate19$10,098
Oxycodone Hcl465$9,839
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen310$9,701
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl42$4,374
Gabapentin352$4,218
Morphine Sulfate122$3,717
Diclofenac Sodium98$3,562
Lidocaine26$2,252
Methadone Hcl103$1,699

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er$447$40,16088 claims
Redhill Biopharma Inc.Movantik$62$19,66240 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,634 family providers in California.

Other family in Modesto

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →